Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Exploring the Impact of Sarcopenia on Overall-Survival, Disease-Free Survival, and Post-operative Complications in Patients with Esophageal Cancer undergoing Curative Intent Therapy

FY 2021-22

Summary
Background: Sarcopenia is defined as the chronic decrease in muscle mass and function. It is part of the aging process, and can be accelerated by disease and malnutrition. In esophageal cancer, sarcopenia is associated with worse survival, increased post-operative complications, and increased risk of malnutrition. Patients with esophageal cancer are higher risk for sarcopenia because the cancer obstructs passage of food into the stomach, patients fast in the post-operative period to facilitate GI tract healing, and the energy requirements of the tumor 'steal' nutrients away from the body's intended purpose.Objectives:Exploring the clinical implications of sarcopenia in esophageal cancer, this research will 1) examine the changes in sarcopenia over a patient's treatment course; and 2) examine the effect of sarcopenia on survival, post-operative complications, and adverse events from chemoradiotherapy.Methods: Patients with esophageal cancer undergo multiple computed tomography (CT) scans during their treatment course and sarcopenia can be measured with the skeletal muscle index calculated from these scans. Study 1 will develop a retrospective cohort study to examine changes in sarcopenia by comparing the skeletal muscle indices across three distinct CT scans: staging, post-chemoradiotherapy, and 6-month post-operative. Data from this retrospective study will be used to guide the prospective second study. Study 2 will develop a multi-institutional prospective cohort study to examine the effect of sarcopenia on clinical outcomes.Significance: This research will solidify our understanding of sarcopenia's prognostic effect in esophageal cancer, which can improve patient outcomes by guiding the development of nutritional interventions for those at-risk.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466518
Name
Jogiat Uzair M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the Impact of Sarcopenia on Overall-Survival, Disease-Free Survival, and Post-operative Complications in Patients with Esophageal Cancer undergoing Curative Intent Therapy
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Body Composition; Esophageal Cancer; Esophagectomy; Intra-Muscular Adipose Content; Nutrition; Oncology; Patient Care; Prognostication; Sarcopenia; Skeletal Muscle Index
Abstract
Background: Sarcopenia is defined as the chronic decrease in muscle mass and function. It is part of the aging process, and can be accelerated by disease and malnutrition. In esophageal cancer, sarcopenia is associated with worse survival, increased post-operative complications, and increased risk of malnutrition. Patients with esophageal cancer are higher risk for sarcopenia because the cancer obstructs passage of food into the stomach, patients fast in the post-operative period to facilitate GI tract healing, and the energy requirements of the tumor 'steal' nutrients away from the body's intended purpose.Objectives:Exploring the clinical implications of sarcopenia in esophageal cancer, this research will 1) examine the changes in sarcopenia over a patient's treatment course; and 2) examine the effect of sarcopenia on survival, post-operative complications, and adverse events from chemoradiotherapy.Methods: Patients with esophageal cancer undergo multiple computed tomography (CT) scans during their treatment course and sarcopenia can be measured with the skeletal muscle index calculated from these scans. Study 1 will develop a retrospective cohort study to examine changes in sarcopenia by comparing the skeletal muscle indices across three distinct CT scans: staging, post-chemoradiotherapy, and 6-month post-operative. Data from this retrospective study will be used to guide the prospective second study. Study 2 will develop a multi-institutional prospective cohort study to examine the effect of sarcopenia on clinical outcomes.Significance: This research will solidify our understanding of sarcopenia's prognostic effect in esophageal cancer, which can improve patient outcomes by guiding the development of nutritional interventions for those at-risk.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jogiat, Uzair M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~